Showing results (21-30 of 183) with videos related to
Sort By:
Pageof 19
Neuroscience|December 1, 2000
The tachykinin NK(1) receptor antagonist SR140333 prevents the increase of nerve growth factor in rat paw skin induced by substance P or neurogenic inflammationR Amann, T Egger, R SchuligoiOnkologie|May 15, 2002
Feasibility and toxicity of weekly Paclitaxel-Carboplatin in 131 patients with pretreated and non-pretreated solid tumorsG D'Addario, R Morant, C Boehme, et al.Onkologie|September 16, 2003
Acute pericarditis and pleural effusion complicating cytarabine chemotherapyA Gähler, F Hitz, U Hess, et al.Lancet (London, England)|March 26, 1994
Prophylaxis and reversal of ifosfamide encephalopathy with methylene-blueA Küpfer, C Aeschlimann, B Wermuth, et al.Onkologie|July 7, 2001
Current Status of Dendritic Cell-Based Tumor VaccinationJ. Dannull, T. Cerny, D.K. Ackermann, et al.Onkologie|February 5, 2003
Postradiation high-grade myofibroblastic sarcoma of the prostate -- a rare entity of prostatic tumors -- responding to liposomal DoxorubicinM Joerger, C Oehlschlegel, T Cerny, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 12, 1998
Comparative pharmacokinetics of oral and intravenous ifosfamide/mesna/methylene blue therapyC Aeschlimann, A Küpfer, H Schefer, et al.Palliative Medicine|March 9, 2007
Fighting a losing battle: eating-related distress of men with advanced cancer and their female partners. A mixed-methods studyF Strasser, J Binswanger, T Cerny, et al.Schweizerische Medizinische Wochenschrift|March 18, 1995
[Diagnosis and therapy of multiple myeloma: current aspects]D C Betticher, T Cerny, M F FeyCurrent Drug Targets|October 21, 2009
The role of pemetrexed in advanced non small-cell lung cancer: special focus on pharmacology and mechanism of actionM Joerger, A Omlin, T Cerny, et al.Pageof 19